Ruxolitinib composition and preparation method therefor
OwnerJin YU, Yanhua LUO +3inventors
InventorsJin YU, Yanhua LUO, Weirui QI, Xiaoxiao WU, Tingting YAN
Life of this patent
Estimating the term…
Loading patent…
OwnerJin YU, Yanhua LUO +3inventors
InventorsJin YU, Yanhua LUO, Weirui QI, Xiaoxiao WU, Tingting YAN
Estimating the term…
Disclosed in the present invention is a Ruxolitinib composition, comprising: Ruxolitinib or a pharmaceutically acceptable salt, an emulsifier, a co-emulsifier, a solvent, and an aqueous phase thereof. The emulsifier comprises one or more of polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil and vitamin E succinic acid. The co-emulsifier comprises propylene glycol monocaprylate. The solvent comprises one or more of propylene glycol, diethylene glycol monoethyl ether, and ethanol. The Ruxolitinib composition of the present invention has an ideal particle size and PDI. Furthermore, the present invention provides Ruxolitinib gel. Compared with a Ruxolitinib cream, the film-permeable efficiency is improved, and the stability of administration to the external skin under the condition of pH 5-7 can be satisfied; compared with the Ruxolitinib cream, as well as commercially available calcipotriol and Benvitimod, the present invention achieves a better drug effect in the aspect of psoriasis treatment.
A ruxolitinib composition, characterized in that the ruxolitinib composition contains a therapeutic agent and an emulsifier, wherein the therapeutic agent is ruxolitinib or a pharmaceutically acceptable salt thereof with a free base-based content of 0.5%-2.0% of the weight of the composition:
A ruxolitinib gel, characterized in that the ruxolitinib gel contains:
Dependencies are inferred from the claim text.